Cedilla Therapeutics vs Sutro Biopharma, Inc.

Cedilla Therapeutics logo

Cedilla Therapeutics

A New Dimension in Precision Oncology

5 employees · est. 2018 · Cambridge, United States

VS
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

Changing the future of Oncology

208 employees · est. 2003 · South San Francisco, United...

Sutro Biopharma, Inc. is the older company (2018 vs 2003); Sutro Biopharma, Inc. is the larger of the two.

Side-by-Side Comparison

Cedilla Therapeutics Sutro Biopharma, Inc.
Founded
2018 2003 older
Headquarters
Cambridge, United States South San Francisco, United States
Employees
5 208 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Information Technology
Funding Stage
Series B IPO
Total Funding
$138.80M $745.90M
Funding Rounds
3 12
Services
Not tracked yet Development of single- and dual-payload ADCs, Oncology research and therapeutics, Scientific and clinical advisory services
Target Customers
Not tracked yet Cancer patients, Healthcare providers, Biopharmaceutical investors, Scientific community
Taxonomy
Precision OncologyProtein FunctionSmall Molecule InhibitorsCancer TargetsTEADCDK2 +7 Oncology TherapeuticsCancer TreatmentAntibody Drug ConjugatesExatecanProtein EngineeringBiopharmaceutical Development +9
Website
cedillatx.com sutrobio.com
Cedilla Therapeutics logo

About Cedilla Therapeutics

Cedilla Therapeutics, founded in 2018, is redefining precision oncology with its innovative approach. Described as "A New Dimension in Precision Oncology," the company focuses on modulating protein function within cells to selectively inhibit oncogenic drivers. Their conditional inhibitors have succ...

Sutro Biopharma, Inc. logo

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a pioneering player in the oncology sector, driven by its commitment to transform cancer treatment. The company, with the slogan "Changing the future of Oncology," leverages its proprietary XpressCF® technology to develop precisely designed cancer therapeutics, aiming to gre...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Cedilla Therapeutics and Sutro Biopharma, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Cedilla Therapeutics or Sutro Biopharma, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Cedilla Therapeutics was founded in 2018, based in Cambridge, United States, with 5 employees. Cedilla Therapeutics, founded in 2018, is redefining precision oncology with its innovative approach. Described as "A New Dimension in Precision Oncology," the company focuses on modulating protein fu. Sutro Biopharma, Inc. was founded in 2003, based in South San Francisco, United States, with 208 employees. Sutro Biopharma, Inc. is a pioneering player in the oncology sector, driven by its commitment to transform cancer treatment. The company, with the slogan "Changing the future of Oncology," leverages i.
Cedilla Therapeutics has raised $138.80M and Sutro Biopharma, Inc. $745.90M. Latest stage: Cedilla Therapeutics Series B, Sutro Biopharma, Inc. IPO.
Both work in Biotechnology.

Compare Cedilla Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cedilla Therapeutics on 12 Sep 2024, and Sutro Biopharma, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes